Log in to save to my catalogue

Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis

Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2642872420

Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis

About this item

Full title

Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis

Publisher

United States: Public Library of Science

Journal title

PloS one, 2022-03, Vol.17 (3), p.e0265642-e0265642

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Diabetic nephropathy (DN), which is correlated with an increased risk of cardiovascular disease, significantly elevates the morbidity and mortality of patients with diabetes. Recently, the benefits of mineralocorticoid receptor antagonists in chronic kidney disease (CKD), such as their anti-inflammatory and anti-fibrotic properties, have been disco...

Alternative Titles

Full title

Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2642872420

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2642872420

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0265642

How to access this item